Skip to content

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

About Us
Our Focus
Pipeline
Partners
Patients
- Overview
- Kid’s Corner
Investors

News

Choose Year
Search Press Releases

Found 176 Results

January 28, 2019

Sernova to Participate on Diabetes Panel and Present at NobleConXV, 15th Annual Investor Conference January 28th – 29th, 2019

January 17, 2019

Sernova Announces Successful Enrollment Approaching 50% of Subjects in its U.S. Phase I/II Cell Pouch Diabetes Clinical Trial

December 20, 2018

Sernova Announces Enrollment of First Patient in U.S. Phase I/II Study of Cell Pouch for Treatment in Type 1 Diabetes

November 20, 2018

Sernova Highlights Achievements from the HemAcure Consortium in Developing a Novel Cell-Based Therapy for Hemophilia A

November 9, 2018

Sernova Retains FronTier Flex for Canadian Investor Relations and Marketing

November 6, 2018

Sernova Establishes Comprehensive North American Investor Relations and Communications Strategy

October 23, 2018

Sernova-HemAcure Consortium to Present Achievements in Development of a Regenerative Medicine Approach to Treat Hemophilia A

July 23, 2018

Sernova Completes Oversubscribed Private Placement of $2,754,000

July 16, 2018

Sernova Announces $2,000,000 First Closing of Private Placement

July 5, 2018

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

«...10...14 15 161718 »

IR Contact

David Burke
Vice President, Investor Relations
917.751.5713
david.burke@sernova.com

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

700 Collip Circle
Suite 114,
London, ON, Canada N6G 4X8
info@sernova.com

Company

About Us
Leadership
Board of Directors
Careers
Contact

Science

Our Focus
Type 1 diabetes
Pipeline
Library

Investors

Overview
News
Events
Financial Reports
Stock Information
Corporate Governance

Privacy Policy
Legal Notice

© 2025 Sernova Biotherapeutics. All rights reserved.

Scroll to Top